Suven Pharmaceuticals Limited – NSE:SUVENPHAR.NS

Suven Pharmaceuticals Limited stock price today

INR 492.35
-675.19
-57.83%
Financial Health
0
1
2
3
4
5
6
7
8
9

Suven Pharmaceuticals Limited stock price monthly change

+37.67%
month

Suven Pharmaceuticals Limited stock price quarterly change

+37.67%
quarter

Suven Pharmaceuticals Limited stock price yearly change

+67.50%
year

Suven Pharmaceuticals Limited key metrics

Market Cap
 287.68B
Enterprise value
 118.58B
P/E
 31.25
EV/Sales
 8.88
EV/EBITDA
 19.55
Price/Sales
 8.87
Price/Book
 7.88
PEG ratio
 1.23
EPS
 11.81
Revenue
 10.51B
EBITDA
 4.48B
Income
 3.00B
Revenue Q/Q
 -31.52%
Revenue Y/Y
 -21.56%
Profit margin
 28.39%
Oper. margin
 38.08%
Gross margin
 56.31%
EBIT margin
 38.08%
EBITDA margin
 42.64%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Suven Pharmaceuticals Limited stock price history

Suven Pharmaceuticals Limited stock forecast

Suven Pharmaceuticals Limited financial statements

Profit Margin

Suven Pharmaceuticals Limited (NSE:SUVENPHAR.NS): Profit margin
Jun 2023 3.47B 1.20B 34.7%
Sep 2023 2.31B 795.64M 34.44%
Dec 2023 2.19B 467.53M 21.27%
Mar 2024 2.52B 533.73M 21.1%
SUVENPHAR.NS income statement history

Suven Pharmaceuticals Limited Financials Estimate

Suven Pharmaceuticals Limited (NSE:SUVENPHAR.NS): Analyst Estimates
2026 14.70B 4.56B 31.04%
2027 17.05B 5.41B 31.76%

  • Analysts Price target

  • Financials & Ratios estimates

Show more
1.29%
Yield TTM
Suven Pharmaceuticals Limited (NSE:SUVENPHAR.NS): Payout ratio
Payout ratio 40.32%
Suven Pharmaceuticals Limited (NSE:SUVENPHAR.NS): Dividend Yield
2019 0.54%
2020 1.5%
2022 0.65%
SUVENPHAR.NS dividends history

Debt to Assets

Suven Pharmaceuticals Limited (NSE:SUVENPHAR.NS): Debt to assets
Jun 2023 0 0
Sep 2023 21197734000 1.84B 8.7%
Dec 2023 20579000000 765M 3.72%
Mar 2024 22540865000 2.03B 9.02%
SUVENPHAR.NS balance sheet history

Cash Flow

Suven Pharmaceuticals Limited (NSE:SUVENPHAR.NS): Cash Flow
Mar 2023 239.16M 0 0
Jun 2023 250.82M 0 0
Sep 2023 237.83M 0 0
Dec 2023 255.03M 0 0
SUVENPHAR.NS cash flow history

Suven Pharmaceuticals Limited alternative data

Suven Pharmaceuticals Limited
Employees

Suven Pharmaceuticals Limited (NSE:SUVENPHAR.NS): Employee count
Aug 2023 1,193
Sep 2023 1,193
Oct 2023 1,193
Nov 2023 1,193
Dec 2023 1,193
Jan 2024 1,193
Feb 2024 1,193
Mar 2024 1,193
Apr 2024 1,193
May 2024 1,193
Jun 2024 1,193
Jul 2024 1,193

Suven Pharmaceuticals Limited other data

Suven Pharmaceuticals Limited
Executives

Insider Compensation
Mr. Venkateswarlu Jasti M.Pharm. M.S. (1949) Chairman & MD
 $81,460,000

Frequently Asked Questions (FAQ)

  • What's the price of Suven Pharmaceuticals Limited stock today?

    One share of Suven Pharmaceuticals Limited stock can currently be purchased for approximately $492.35.

  • When is Suven Pharmaceuticals Limited's next earnings date?

    Unfortunately, Suven Pharmaceuticals Limited's (SUVENPHAR.NS) next earnings date is currently unknown.

  • Does Suven Pharmaceuticals Limited pay dividends?

    Yes, Suven Pharmaceuticals Limited pays dividends and its trailing 12-month yield is 1.29% with 40% payout ratio. The last Suven Pharmaceuticals Limited stock dividend of $0 was paid on 12 Sep 2025.

  • How much money does Suven Pharmaceuticals Limited make?

    Suven Pharmaceuticals Limited has a market capitalization of 287.68B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 18.49% to 10.51B US dollars.

  • What is Suven Pharmaceuticals Limited's stock symbol?

    Suven Pharmaceuticals Limited is traded on the NSE under the ticker symbol "SUVENPHAR.NS".

  • What is Suven Pharmaceuticals Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Suven Pharmaceuticals Limited?

    Shares of Suven Pharmaceuticals Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Suven Pharmaceuticals Limited's key executives?

    Suven Pharmaceuticals Limited's management team includes the following people:

    • Mr. Venkateswarlu Jasti M.Pharm. M.S. Chairman & MD(age: 76, pay: $81,460,000)

  • How many employees does Suven Pharmaceuticals Limited have?

    As Jul 2024, Suven Pharmaceuticals Limited employs 1,193 workers.

  • When Suven Pharmaceuticals Limited went public?

    Suven Pharmaceuticals Limited is publicly traded company for more then 5 years since IPO on 9 Mar 2020.

  • What is Suven Pharmaceuticals Limited's official website?

    The official website for Suven Pharmaceuticals Limited is suvenpharm.com.

  • How can i contact Suven Pharmaceuticals Limited?

    Suven Pharmaceuticals Limited can be reached via phone at +91 40 2354 9414.

Suven Pharmaceuticals Limited company profile:

Suven Pharmaceuticals Limited

suvenpharm.com
Exchange:

NSE

Full time employees:

1,193

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.

+91 40 2354 9414
# 8-2-334, SDE Serene Chambers
Hyderabad, 500034

:
ISIN: INE03QK01018
CUSIP: Y831GW103